Takeda Pharmaceutical Company Limited
Heterocyclic amide compound

Last updated:

Abstract:

Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): ##STR00001## wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

Status:
Grant
Type:

Utility

Filling date:

14 Sep 2017

Issue date:

13 Oct 2020